Wnt signaling inhibition by monensin results in a period of Hippo pathway activation during intestinal adaptation in zebrafish

Abstract

Intestinal adaptation (IA) is a critical response to increase epithelial surface area after intestinal loss. Short bowel syndrome (SBS) may follow massive intestinal resection in human patients, particularly without adequate IA. We previously validated a model in zebrafish (ZF) that recapitulates key SBS pathophysiological features. Previous RNA sequencing in this model identified upregulation of genes in the Wnt and Hippo pathways. We therefore sought to identify the timeline of increasing cell proliferation and considered the signaling that might underpin the epithelial remodeling of IA in SBS. SBS was created in a ZF model as previously reported and compared with sham fish with and without exposure to monensin, an ionophore known to inhibit canonical Wnt signaling. Rescue of the monensin effects was attempted with a glycogen synthase kinase 3 inhibitor that activates wnt signaling, CHIR-99021. A timeline was constructed to identify peak cellular proliferation, and the Wnt and Hippo pathways were evaluated. Peak stem cell proliferation and morphological changes of adaptation were identified at 7 days. Wnt inhibition diminished IA at 2 wk and resulted in activation of genes of the Wnt/β-catenin and Yes-associated protein (YAP)/Hippo pathway. Increased cytoplasmic YAP was observed in monensin-treated SBS fish. Genes of the WASP-interacting protein (WIP) pathway were elevated during Wnt blockade. In conclusion, cellular proliferation and morphological changes accompany SBS even in attempted Wnt blockade. Wnt/β-catenin, YAP/Hippo pathway, and WIP pathway genes increase during early Wnt blockade. Further understanding of the effects of Wnt and YAP pathway signaling in proliferating stem cells might enrich our knowledge of targets to assist IA. NEW & NOTEWORTHY Intestinal adaptation is a critical response to increase epithelial surface area after large intestinal losses. Inhibition of Wnt/β-catenin signaling impairs intestinal adaptation in a zebrafish model of short bowel syndrome. There is a subsequent upregulation in genes of the Yes-associated protein/Hippo and WIP pathway. These may be targets for future human therapies, as patients are salvaged by the compensation of increased intestinal epithelial surface area through successful intestinal adaptation.

Broad-spectrum antibiotics alter the microbiome, increase intestinalfxr, and decrease hepatic steatosis in zebrafish short bowel syndrome

“…After 14 days, SBS fish lost a significant amount of weight compared with Sham fish (75.6 Ϯ 3.1 vs. 97.1 Ϯ 3.9%, P Ͻ 0.0001; Fig. 1, A and B), consistent with prior studies (3,24,48,50). Despite receiving broad-spectrum antibiotics, ShamϩAbx and SBSϩAbx fish displayed similar postoperative weight curves when compared with sham and SBS fish (Fig.…”

Lithium Chloride rescues Monensin-potentiated Wnt signaling inhibition in inflammatory bone loss in rats

“…Downstream the pathway it was evaluated to role of beta-catenin, and both genetic and protein expressions were restored by the use of LiCl in animals with periodontitis receiving Mon [16,45]. It has been reported that Mon inhibits beta-catenin but LiCl can provide a greater expression of beta-catenin, in turn.…”

Inhibition of Wnt/β-catenin signaling by monensin in cervical cancer

“…The anticancer attributes of monensin are ascribed to its capability to induce oxidative stress and inhibit signaling pathways involving mTOR, MYB, and growth factor receptors. Several studies have reported that monensin exerts inhibitory effects on canonical Wnt/β-catenin signaling [ 21 - 23 ].…”